Lexaria Bioscience Corp.: Lexaria Welcomes Dr. Catherine Tur

KELOWNA, BC / ACCESSWIRE / September 2, 2022 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms is pleased to announce that

Related Keywords

Chris Bunka , Catherine Turkel , George Jurcic , Eledon Pharmaceuticals , Lexaria Bioscience Corp , Drug Administration , Nasdaq , Translational Scientific Advisory Committee , Exchange Commission , Prostate Cancer Research , Company Or Lexaria , Allergan , Lexaria Bioscience , Lexaria Board , Nezee Therapeutics , Novus Therapeutics , Board Director , Object Pharma , Dean Advisor , Chapman University School , Rare Diseases , Chronic Migraine , Lexaria , Ioscience , Orp , Elcomes , Catherine , Murkel , Board , Directors ,